Imlimthan S - Search Results

1

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.

Imlimthan S, Moon ES, Rathke H, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E. Imlimthan S, et al. Pharmaceuticals (Basel). 2021 Oct 5;14(10):1023. doi: 10.3390/ph14101023. Pharmaceuticals (Basel). 2021. PMID: 34681246 Free PMC article. Review.

2

Evaluation of Organo [¹⁸F]Fluorosilicon Tetrazine as a Prosthetic Group for the Synthesis of PET Radiotracers.

Otaru S, Imlimthan S, Sarparanta M, Helariutta K, Wähälä K, Airaksinen AJ. Otaru S, et al. Among authors: imlimthan s. Molecules. 2020 Mar 7;25(5):1208. doi: 10.3390/molecules25051208. Molecules. 2020. PMID: 32156020 Free PMC article.

3

Development of [¹⁸F]AmBF₃ Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [¹⁸F]AmBF₃-PEG₇-Tyr³-Octreotide in an AR42J Pancreatic Carcinoma Model.

Otaru S, Paulus A, Imlimthan S, Kuurne I, Virtanen H, Liljenbäck H, Tolvanen T, Auchynnikava T, Roivainen A, Helariutta K, Sarparanta M, Airaksinen AJ. Otaru S, et al. Among authors: imlimthan s. Bioconjug Chem. 2022 Jul 20;33(7):1393-1404. doi: 10.1021/acs.bioconjchem.2c00231. Epub 2022 Jun 16. Bioconjug Chem. 2022. PMID: 35709482 Free PMC article.

4

Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications.

Imlimthan S, Otaru S, Keinänen O, Correia A, Lintinen K, Santos HA, Airaksinen AJ, Kostiainen MA, Sarparanta M. Imlimthan S, et al. Biomacromolecules. 2019 Feb 11;20(2):674-683. doi: 10.1021/acs.biomac.8b01313. Epub 2018 Nov 9. Biomacromolecules. 2019. PMID: 30380842

5

Site-Specific ¹¹¹In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model.

Lumen D, Näkki S, Imlimthan S, Lambidis E, Sarparanta M, Xu W, Lehto VP, Airaksinen AJ. Lumen D, et al. Among authors: imlimthan s. Pharmaceutics. 2019 Dec 17;11(12):686. doi: 10.3390/pharmaceutics11120686. Pharmaceutics. 2019. PMID: 31861119 Free PMC article.

6

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [⁸⁹Zr]Zr-DFO-PEG₅-Tz.

Lumen D, Vugts D, Chomet M, Imlimthan S, Sarparanta M, Vos R, Schreurs M, Verlaan M, Lang PA, Hippeläinen E, Beaino W, Windhorst AD, Airaksinen AJ. Lumen D, et al. Among authors: imlimthan s. Bioconjug Chem. 2022 May 18;33(5):956-968. doi: 10.1021/acs.bioconjchem.2c00164. Epub 2022 Apr 20. Bioconjug Chem. 2022. PMID: 35442642 Free PMC article.

7

Development of ⁶⁸Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET.

Lambidis E, Chen CC, Baikoghli M, Imlimthan S, Khng YC, Sarparanta M, Cheng RH, Airaksinen AJ. Lambidis E, et al. Among authors: imlimthan s. Mol Pharm. 2022 Aug 1;19(8):2971-2979. doi: 10.1021/acs.molpharmaceut.2c00359. Epub 2022 Jul 20. Mol Pharm. 2022. PMID: 35857429 Free PMC article.

8

Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with ¹⁵⁵Tb.

Jakobsson U, Mäkilä E, Rahikkala A, Imlimthan S, Lampuoti J, Ranjan S, Heino J, Jalkanen P, Köster U, Mizohata K, Santos HA, Salonen J, Airaksinen AJ, Sarparanta M, Helariutta K. Jakobsson U, et al. Among authors: imlimthan s. Nucl Med Biol. 2020 May-Jun;84-85:102-110. doi: 10.1016/j.nucmedbio.2020.04.001. Epub 2020 Apr 10. Nucl Med Biol. 2020. PMID: 32334356 Free article.

9

Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics.

Lumen D, Wang S, Mäkilä E, Imlimthan S, Sarparanta M, Correia A, Westerveld Haug C, Hirvonen J, Santos HA, Airaksinen AJ, Filtvedt W, Salonen J. Lumen D, et al. Among authors: imlimthan s. Eur J Pharm Biopharm. 2021 Jan;158:254-265. doi: 10.1016/j.ejpb.2020.11.022. Epub 2020 Dec 3. Eur J Pharm Biopharm. 2021. PMID: 33279602 Free article.

10

Radiolabeling of Theranostic Nanosystems.

Das S, Imlimthan S, Airaksinen AJ, Sarparanta M. Das S, et al. Among authors: imlimthan s. Adv Exp Med Biol. 2021;1295:49-76. doi: 10.1007/978-3-030-58174-9_3. Adv Exp Med Biol. 2021. PMID: 33543455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page